← Leaderboards
Robert P Lanza
Advanced Cell Technology
$1,457,900
Attributed
$2,626,950
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2010–15$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,626,950 · 4
By mechanism
RC4$1,896,390 · 1
R43$441,711 · 2
R01$288,849 · 1
Top collaborators
- Erin Kimbrel1 shared
- Kwang-Soo Kim1 shared
- Shi-Jiang Lu1 shared
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseTissuesSourceCellsBiotechnologyCell TherapyIn VitroProgramsNeuronsPropertyLeadLymphocyteInduced Pluripotent Stem CellAnimalsGeneticInvestigationClinical TrialsCombatDoseEmbryonic Stem CellGenetic ManipulationHuman Embryonic Stem CellAnimal ModelCell Line
Grant awards (4)
Human embryonic stem cell-derived mesenchymal stromal cell therapy for lupus nephritis$225,639
R43 · FY2015 · AI · contact PI
Retinitis pigmentosa therapy with human embryonic stem cell- and induced pluripotent stem cell-derived photoreceptor progenitors$216,072
R43 · FY2015 · EY · contact PI
Patient-specific and universal donor blood cell from protein-induced iPS cells$1,896,390
RC4 · FY2010 · HL
Defining Critical Parameters of Mouse Cloning$288,849
R01 · FY2001 · HD